Werewolf Therapeutics, Inc.Werewolf Therapeutics, Inc.Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc.

No trades
See on Supercharts

Price target

12.000.000.00%
The 6 analysts offering 1 year price forecasts for HOWL have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to HOWL in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


HOWL EPS for the last quarter is −0.38 USD despite the estimation of −0.41 USD. In the next quarter EPS is expected to reach −0.42 USD. Track more of Werewolf Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Werewolf Therapeutics, Inc. revenue is expected to reach ‪301.59 K‬ USD. Check out Werewolf Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, HOWL price target is 12.00 USD with a max estimate of 15.00 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Werewolf Therapeutics, Inc. stock price chart and keep track of the current situation with HOWL news and stock market news.
We've gathered opinions of 6 analysts rating HOWL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.